Abstract:Objective To construct prokaryotic expression vector of BC047440 gene to express and purify its recombinant protein. Methods The total RNA was extracted from HepG2 cells. The BC047440 gene fragment was amplified from the total RNA by RT-PCR. The resulting product was cloned into pMD19-T vector and sequenced. Then the confirmed BC047440 cDNA was cloned into plasmid pET-28a( + ) and transformed into E. coli BL21 where it was induced to express proteins by i-sopropyl-1-thio-b-Dgalactopyranoside (IPTG). The expression of protein was analyzed through SDS-PAGE cells induced for 3 h by IPTG harvesting. Then it was sonicated briefly and the proteins were purified through affinity chromatography. Results The target sequences were specifically amplified through RT-PCR, cloned into pMD19-T vector, and then transformed into E. coli DH5a. Five white colonies were selected and cut by BamHI and EcoRl separately. The plasmids of two white colonies showed positive results and was sequenced, demonstrating to be the same as that of BC047440 gene in GenBank. Then BC047440 cDNA was cut down from pMD19-T, ligated into the vector pET-28a( + ) and then transformed into E. coli BL21. After an overnight incubation, seven white colonies were picked and showed positive results after being digested by both BamHI and EcoRI. After IPTG induction of one positive colony, a new protein band about Mr 23000 showed on SDS-PAGE. The percentage of expressed product over total bacterial proteins after 4 hours of induction was 22. 3%. After affinity chromatography, SDS-PAGE showed only one clear band existed in 50 mmol/L or 125 mmol/L imidizone elution. Conclusion The prokaryotic expression vector of BC047440 gene has been successfully constructed. Meanwhile, purified recombinant proteins are obtained through affinity chromatography, laying foundation for further study of its clinical use.

Construction of the Prokaryotic Expression Vector of Human Tissue-Type Plasminogen Activator and Its Preliminary Expression in Escherichia coli

Construction of Eukaryotic Expression Plasmid Containing Tpa Genes and Its Expression in Transfected VSMCs

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Construction and Biological Activities of Human Tpa Eukaryotic Expression Plasmid.

Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli

Expression of the Recombinant Plasminogen Activator (rpa) and Its Mutants

Expression of Active Recombinant Human Tissue-Type Plasminogen Activator by Using in Vivo Polyhydroxybutyrate Granule Display

Construction of retroviral vector with tissue type plasminogen activator gene and culture of pure packaging cell line

Construction and Identification of the Lentiviral Expression Vector with Human TPA Gene

Expression of Activity Reteplase in E.coli

Experimental Study on Establishing Eukaryotic Expression Vector Pcdna3.1(+) TPA and Its Expressing Activity in Human Skin Fibroblists.

Construction of expression vector pcDNA3.1(+)TPA and its expressing activity after transfecting into human skin fibroblasts

Construction and identification of eukaryotic expression vector of tissue factor pathway inhibitor-2 gene

[Construction of Co-Expression Plasmid Containing Tpa and VEGF165 Genes and Its Expression in VSMCs].

Molecular cloning and expression of rgpA and rgpB proteinase region genes of Porphyromonas gingivalis

Active Expression of Human Tissue Plasminogen Activator (t-PA) c-DNA from Pulmonary Metastases in the Methylotrophic Yeast Pichia Pastoris KM71H Strain

High-Level Expression of Active Human Plasminogen Activator Inhibitor Type 1 (Pai-1) in E-Coli

In vivo expression of human tissue-plasminogen activator transfected AGZY83-a cells implanted in mice

[Constructing the Recombinant of Pet28a-Tat-lacz].

Constrution of Tetracycline -Inducible Mice Urokinase Plasminogen Activator Eukaryotic Expression Vector and its Expression in Huh7 Cells

Expression of Human Tissue -Type Plasminogen Activator in Transgenic Tobacco